Amgen is trading 3.5% up today at $389.50 as the stock benefits from a broader rally across the biotech sector, outperforming a mixed market backdrop.
- There are no fresh, company-specific headlines or earnings reports today; the move appears to be driven by industry-wide sentiment.
- Biotech ETFs are gaining momentum following blockbuster M&A activity and positive clinical trial data reported by industry peers.